Mobi724 Global Solutions Inc. Closes the Last Portion of the Acquisition with Former Shareholders of I.Q. 7/24 Inc. on Better Terms to Focus on its Growth Strategy Plan

Mobi724 Global Solutions Inc. Closes the Last Portion of the Acquisition with Former Shareholders of I.Q. 7/24 Inc. on Better Terms to Focus on its Growth Strategy Plan

MONTREAL, QUEBEC — (Marketwired) — 05/11/17 — MOBI724 Global Solutions Inc. ("MOBI724" or the "Company") (CSE: MOS)(CSE: MOS.CN)(CNSX: MOS)(OTCQB: MOBIF), a Fintech leader offering all in one fully integrated EMV payment, card link couponing and digital marketing, announces that it has successfully renegotiated the terms of the balance of sale of the acquisition of its wholly owned subsidiary I.Q. 7/24 Inc ("IQ") and that it has paid the IQ former shareholders

“No data scientists, no problem,” DataSift tells agencies as it launches Media Strategies API

“No data scientists, no problem,” DataSift tells agencies as it launches Media Strategies API

SAN FRANCISCO, CA — (Marketwired) — 05/11/17 — DataSift today unveiled its new Media Strategies API, enabling marketing agencies to instantly access actionable intelligence from social data to inform their marketing strategy, media planning, and campaign development. The Media Strategies API is initially available as part of the PYLON for LinkedIn Engagement Insights platform, which provides organizations with advanced insights into the activities and interests of more than .Using the new AP

PELOBiotech gets exclusive European distribution rights for ReachBio?s full product line for the life science research market

PELOBiotech GmbH (Planegg, Germany) has signed an agreement with ReachBio Research Labs (Seattle, WA, USA) giving PELOBiotech exclusive distribution rights to ReachBio?s full product line for the life science research market within Europe.
ReachBio provides research products and contract services (cellPrism® drug development platform) for applications in basic life science research, drug research & development, toxicology and immunology. The company?s main product lines consist